Modelling the impact of using a DNA compared to mRNA HPV assay as part of the cervical screening programmes in Sweden and Denmark
Estimating the costs and benefits of HR-HPV assay choice in a theoretical HPV primary cervical screening algorithm in Ontario, Canada
Evaluating the choice of HPV assay in the French cervical screening programme with a decision tree model
Exploring HCV eradication through diagnosis and treatment strategies
Mapping the treatment pathway for metastatic uveal melanoma patients in England: A qualitative pilot study
Using real world evidence to characterise a cohort of metastatic uveal melanoma patients in England
Quantifying standard of care hospital-related resource utilisation for metastatic uveal melanoma patients in England
Evaluating the costs, benefits and cost-effectiveness of multi-pathogen point-of-care tests for sexually transmitted infections
Modelling the burden of non-muscle-invasive bladder cancer in Europe
How to prevent cervical cancer: HPV – we are coming to get you!
